all the information, none of the junk | biotech • healthcare • life sciences

Synthetic Genomics Recruits Illumina Exec

Synthetic Genomics, the San Diego biofuels developer, today named a top executive from San Diego-based Illumina (NASDAQ: ILMN), the maker of genetic sequencing tools, as its chief operating officer. Joel McComb, a senior vice president and general manager of Illumina’s $650 million life sciences business unit, will start March 1 and report to J. Craig Venter, Synthetic Genomics founder and CEO.

By posting a comment, you agree to our terms and conditions.